Skip to main content

Friday, Jan. 22, 2016, 31 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $197.25 to $13,944,713.80.

Highlighted Stocks Traded by Insiders:

Trupanion (TRUP) - FREE Research Report

Rawlings Darryl, who is President and CEO at Trupanion, sold 3,500 shares at $7.92 on Jan. 22, 2016. Following this transaction, the President and CEO owned 1.6 million shares meaning that the stake was reduced by 0.22% with the 3,500-share transaction.

The shares most recently traded at $8.00, up $0.08, or 1.05% since the insider transaction. Historical insider transactions for Trupanion go as follows:

  • 4-Week # shares sold: 3,500
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 17,500
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 35,000

The average volume for Trupanion has been 91,900 shares per day over the past 30 days. Trupanion has a market cap of $226.8 million and is part of the financial sector and insurance industry. Shares are down 18.03% year-to-date as of the close of trading on Friday.

Trupanion, Inc., together with its subsidiaries, operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs in the United States, Canada, and Puerto Rico. Currently, there are 2 analysts who rate Trupanion a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRUP - FREE

TheStreet Quant Ratings

rates Trupanion as a

sell

. Among the areas we feel are negative, one of the most important has been poor profit margins. Get the full

Trupanion Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Intersect ENT (XENT) - FREE Research Report

Kaufman Richard E, who is Sr VP& Chief Operating Officer at Intersect ENT, sold 7,206 shares at $17.93 on Jan. 22, 2016. Following this transaction, the Sr VP& Chief Operating Officer owned 208,983 shares meaning that the stake was reduced by 3.33% with the 7,206-share transaction.

The shares most recently traded at $18.34, up $0.41, or 2.24% since the insider transaction. Historical insider transactions for Intersect ENT go as follows:

  • 4-Week # shares sold: 4,500
  • 12-Week # shares sold: 18,138
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 48,592

The average volume for Intersect ENT has been 396,500 shares per day over the past 30 days. Intersect ENT has a market cap of $512.9 million and is part of the health care sector and health services industry. Shares are down 17.11% year-to-date as of the close of trading on Friday.

Intersect ENT, Inc., a commercial stage drug-device company, provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. It offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis. Currently, there are 8 analysts who rate Intersect ENT a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XENT - FREE

TheStreet Quant Ratings

rates Intersect ENT as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

Intersect ENT Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Electronic Arts (EA) - FREE Research Report

Toledano Gabrielle B, who is EVP, Chief Talent Officer at Electronic Arts, sold 4,000 shares at $66.27 on Jan. 22, 2016. Following this transaction, the EVP, Chief Talent Officer owned 72,480 shares meaning that the stake was reduced by 5.23% with the 4,000-share transaction.

The shares most recently traded at $69.89, up $3.62, or 5.18% since the insider transaction. Historical insider transactions for Electronic Arts go as follows:

  • 4-Week # shares sold: 18,000
  • 12-Week # shares sold: 159,579
  • 24-Week # shares sold: 231,361

The average volume for Electronic Arts has been 4.0 million shares per day over the past 30 days. Electronic Arts has a market cap of $20.8 billion and is part of the technology sector and computer software & services industry. Shares are up 0.93% year-to-date as of the close of trading on Friday.

Electronic Arts Inc. develops, markets, publishes, and distributes game software content and online services for video game consoles, Internet-connected consoles, personal computers, mobile phones, and tablets worldwide. The company operates through EA Studios, EA Mobile, and Maxis divisions. The company has a P/E ratio of 26.4. Currently, there are 13 analysts who rate Electronic Arts a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EA - FREE

TheStreet Quant Ratings

rates Electronic Arts as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, notable return on equity and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Electronic Arts Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.